A detailed history of Middleton & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Middleton & CO Inc holds 736 shares of LLY stock, worth $565,071. This represents 0.07% of its overall portfolio holdings.

Number of Shares
736
Previous 736 -0.0%
Holding current value
$565,071
Previous $666,000 2.1%
% of portfolio
0.07%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $14,805 - $19,807
-25 Reduced 3.29%
736 $572,000
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $11,302 - $15,581
-26 Reduced 3.3%
761 $408,000
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $176,956 - $219,604
787 New
787 $217,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Middleton & CO Inc Portfolio

Follow Middleton & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Middleton & CO Inc with notifications on news.